EuroEyes International Eye Clinic Limited stock analysis
Want to see HK:1846 full AI Analyst Report?
EuroEyes International Eye Clinic Limited (1846) Stock Price & Analysis
1846 Stock Chart & Stats
- Day’s Range
- HKD 2.08 - HKD 2.08
- 52-Week Range
- HKD 2.08 - HKD 3.30
- Previous Close
- HKD 2.10
- Volume
- N/A
- Average Volume (3M)
- 37.00K
- Market Cap
- HKD 671.52M
- Enterprise Value
- HKD 565.51M
- Total Cash (Recent Filing)
- HKD 607.70M
- Total Debt (Recent Filing)
- HKD 387.46M
- Price to Earnings (P/E)
- 270.1
- Beta
- 0.19
- Next Earnings
- Mar 31, 2027 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Jul 03, 2026
- Dividend Yield
- 2.12%
Bulls Say, Bears Say
Bulls Say
Revenue Growth Resumed
The return to measurable revenue growth indicates renewed demand for EuroEyes’ paid ophthalmology services and improving clinic activity. If sustained, higher volumes can support operating leverage, strengthen the network’s market position, and provide a broader base for restoring earnings over the next several quarters.
Strong Cash Generation
Consistently positive operating cash flow and higher 2025 free cash flow demonstrate that the clinic network converts activity into meaningful internal funding. This supports ongoing investment, debt service, and shareholder distributions while reducing reliance on external financing for ordinary business needs.
Substantial Equity Backing
A substantial equity base provides EuroEyes with financial resilience and capacity to absorb operating variability across its clinics. Strong equity support can also preserve strategic flexibility for investment in clinical capabilities, network development, and patient-facing services through the medium term.
Bears Say
Profitability Deterioration
The decline in net income despite revenue growth indicates that recent expansion is not translating efficiently into earnings. Lower operating profit suggests margin compression or higher costs, creating a durable challenge for rebuilding profitability and limiting the quality of near-term growth.
Higher Total Debt
Higher debt increases fixed financial obligations and reduces flexibility if clinic performance or investment needs fluctuate. Although historical leverage was described as manageable, the 2025 increase means more balance-sheet resources may be directed toward financing costs and repayment rather than growth.
Lower Capital Efficiency
The sharp ROE decline shows that the enlarged equity base is currently generating weaker returns. Persistently lower capital efficiency would reduce the economic benefit of reinvestment, make profitable expansion harder to achieve, and signal that recent earnings weakness is not merely temporary revenue softness.
EuroEyes International Eye Clinic Limited News
EuroEyes Bolsters European Push with Appointment of New Executive Director
The latest announcement is out from EuroEyes International Eye Clinic Limited ( ($HK:1846) ). EuroEyes International Eye Clinic Limited has appointed 60-year-old Rens Laurentius Michaël Schoenmakers as an executive director
EuroEyes Completes Major Acquisition to Expand Dutch Eye-Clinic Network
EuroEyes International Eye Clinic Limited ( ($HK:1846) ) has provided an announcement. EuroEyes International Eye Clinic Limited has completed a very substantial acquisition and connected transaction involving EuroEyes Netherlands, marking
EuroEyes shareholders back strategic deals and option arrangements at EGM
EuroEyes International Eye Clinic Limited ( ($HK:1846) ) has shared an announcement. Shareholders of EuroEyes International Eye Clinic Limited overwhelmingly approved all resolutions at an extraordinary general meeting held on
1846 FAQ
What was EuroEyes International Eye Clinic Limited’s price range in the past 12 months?
What is EuroEyes International Eye Clinic Limited’s market cap?
When is EuroEyes International Eye Clinic Limited’s upcoming earnings report date?
How were EuroEyes International Eye Clinic Limited’s earnings last quarter?
Is EuroEyes International Eye Clinic Limited overvalued?
Does EuroEyes International Eye Clinic Limited pay dividends?
What is EuroEyes International Eye Clinic Limited’s EPS estimate?
How many shares outstanding does EuroEyes International Eye Clinic Limited have?
What happened to EuroEyes International Eye Clinic Limited’s price movement after its last earnings report?
Which hedge fund is a major shareholder of EuroEyes International Eye Clinic Limited?
What is the TipRanks Smart Score and how is it calculated?
EuroEyes International Eye Clinic Limited Stock Smart Score
Company Description
EuroEyes International Eye Clinic Limited
EuroEyes International Eye Clinic Limited provides vision correction services in Germany, the People’s Republic of China, Denmark, and the United Kingdom. The company offers laser eye surgery in various options, including SMILE Pro, Femto-Lasik, PRK, and Lasek; refractive laser surgery, such as ReLEx SMILE, Femto LASIK, and Presbyond; lens exchange surgery comprising monofocal and trifocal lens exchange surgery; and PRK/LASEK and ICRS implantation services. It also sells pharmaceutical products; rental of ophthalmic equipment and operating spaces; and provides training service. In addition, the company is involved in the operation of consultation centers and/or clinics for eye treatment, as well as LASIK centers; and trading of eye clinic equipment and lenses. EuroEyes International Eye Clinic Limited was founded in 1993 and is headquartered in Hamburg, Germany.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Jørn Slot Jørgensen
- Employees
- 409
- Website
- www.euroeyes.hk
- Address
- Valentinskamp 90, Hamburg, CQ, 20355, DE
EuroEyes International Eye Clinic Limited (1846) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 5 | 3 | 14 |
| Technical Analysis | 5 | 3 | 2 |
| Moving Averages | 0 | 0 | 12 |








